… neurotoxicity due to antineoplastic therapy are given. Recommendations regarding immune-…
the ESMO Clinical Practice Guidelines on ‘Management of toxicities from immunotherapy’. …

… of time and caused significant … cancer who engage in at least 3–5 hours of moderate activity
weekly may experience better outcomes and have fewer side-effects of anticancer therapy…

… may be beneficial for the prevention of RT-induced or RT-CT–induced diarrhea in patients …
current set of clinical practical guidelines. A long-term OM complication of cancer therapy was …

… decisions and improve cancer care, and that all patients should have … guidelines are
ultimately reviewed and approved by the Expert Panel and the ASCO Clinical Practice Guidelines …

… that of cytotoxic chemotherapy or targeted anticancer therapy. … those sen with conventional
anticancer therapies, though their … who discontinued therapy during the induction phase (in …

… treatment is a type of adoptive cell therapy and can be referred to as a “living drug.” The intent
of CAR T-cell therapy is to induce … Currently approved CAR T-cell anticancer therapies are …

… Cancer clinical practice guidelines, which are based on a systematic review of the literature
published up to December, 2018, are presented along with a Grading of Recommendations …

… Managment for irAEs also differs from those for AEs with conventional cancer therapies.
Treatment for … In addition to being a toxicity induced by ICI therapy, arthralgia is also a known …

… The pandemic caused by the novel coronavirus SARS-CoV-2 has disrupted almost all
aspects of the healthcare system, including cancer care. Treatment plans for patients undergoing …

… than other patients with chemotherapy-induced anemia. The mechanisms of … recommendations
on the best practices in disease management to provide the highest level of cancer care…